Drug Profile
ADL 100116
Alternative Names: ADL 0100016; ADL 10-0116Latest Information Update: 10 Jul 2006
Price :
$50
*
At a glance
- Originator Adolor Corporation
- Class Analgesics
- Mechanism of Action Opioid kappa receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 10 Jul 2006 No development reported - Phase-I for Pain in USA (PO)
- 14 Sep 2001 Phase-I clinical trials for Pain in USA (PO)
- 27 Jul 2001 Preclinical development for Pain in USA (PO)